Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of fospropofol disodium in hepatic impairment
ChiCTR2400085355Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fospropofol disodium in hepatic impairment (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Pharmacokinetic parameters of fospropofol disodium/propofol. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
hepatic impairment
Beyond the preview
Go deeper on ChiCTR2400085355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085355.